aTyr Pharma ATYR Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $190K-19.1% | $235K-33.4% | $353K— | —— | ||
| $60.22M+10.8% | $54.37M+28.6% | $42.29M-1.2% | $42.81M+84.0% | ||
| $17.6M+27.7% | $13.78M+6.1% | $12.98M-7.2% | $13.98M+30.1% | ||
| $77.82M+14.2% | $68.15M+23.3% | $55.27M-2.7% | $56.79M+67.0% | ||
| -$77.63M-14.3% | -$67.91M-23.7% | -$54.92M-18.3% | -$46.4M-36.4% | ||
| -40,856.3%-11,957pp | -28,899.6%-13,342pp | -15,557.8%— | —— | ||
| $3.5M-10.0% | $3.89M-13.9% | $4.52M+326% | $1.06M+346% | ||
| -$74.12M-15.8% | -$64.02M-27.1% | -$50.39M-11.1% | -$45.34M-34.3% | ||
| -39,009.5%-11,766pp | -27,243.8%-12,969pp | -14,274.5%— | —— | ||
| -$0.79+8.1% | -$0.86+10.4% | -$0.96+40.0% | -$1.60+10.1% | ||
| -$76.96M-14.5% | -$67.21M-23.7% | -$54.33M-17.7% | -$46.17M-37.7% | ||
| -40,506.8%-11,909pp | -28,598.3%-13,208pp | -15,390.1%— | —— | ||
| -$77.63M-14.3% | -$67.91M-23.7% | -$54.92M-18.3% | -$46.4M-36.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is aTyr Pharma's revenue?
- aTyr Pharma (ATYR) generated $190.0K in revenue over the trailing twelve months, down 19.1% year over year.
- Is aTyr Pharma profitable?
- aTyr Pharma is not currently profitable: it reported a net loss of $70.0M over the trailing twelve months, a -39009.5% net margin.
- What is aTyr Pharma's earnings per share?
- aTyr Pharma's diluted EPS over the trailing twelve months is $-0.73.
- Where does aTyr Pharma's income statement data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
